Thus, for hepatocellular carcinoma and oral cancer, the results suggest that the activation of ERK1/2, p38, and JNK may play a crucial role in polarizing TAMs toward the M2 phenotype. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.